2-(2,3-dicarboxycyclopropyl)glycine has been researched along with sb 203580 in 1 studies
Studies (2-(2,3-dicarboxycyclopropyl)glycine) | Trials (2-(2,3-dicarboxycyclopropyl)glycine) | Recent Studies (post-2010) (2-(2,3-dicarboxycyclopropyl)glycine) | Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) |
---|---|---|---|---|---|
166 | 0 | 27 | 3,489 | 4 | 1,137 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anwyl, R; Gisabella, B; Rowan, MJ | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and sb 203580
Article | Year |
---|---|
Mechanisms underlying the inhibition of long-term potentiation by preconditioning stimulation in the hippocampus in vitro.
Topics: Animals; Anticonvulsants; Cyclopropanes; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Flavonoids; Glycine; Hippocampus; Imidazoles; In Vitro Techniques; Long-Term Potentiation; Male; Methoxyhydroxyphenylglycol; Neural Inhibition; Pyridines; Rats; Rats, Wistar; Synapses; Time Factors | 2003 |